Radiopharmaceuticals: all 1,299 studies that test it

Page 6 of 13. Open to participants first (296), then studies with results posted, then the rest; newest registration first within each.

• A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy VolunteersCompletedNCT01565330Phase 1Results posted
• A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly VolunteersCompletedNCT01565291Early Phase 1Results posted
• A Study of 18F-AV-45 in Healthy VolunteersCompletedNCT01564706Phase 1Results posted
• Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET ScansCompletedNCT01550549Not applicableResults posted
• Clinical Evaluation of Florbetapir F 18 (18F-AV-45)CompletedNCT01518374Phase 2Results posted
• Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like TherapyTerminatedNCT01510184Phase 3Results posted
• PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell CarcinomaTerminatedNCT01502228Not applicableResults posted
• Half-Dose Radiopharmaceutical in Wide Beam ReconstructionTerminatedNCT01499654Not applicableResults posted
• Zevalin and Velcade in Relapsed/Refractory Mantle Cell LymphomaTerminatedNCT01497275Phase 2Results posted
• Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)CompletedNCT01490723Phase 2Results posted
• Imaging Study for FdCyd and THU Cancer TreatmentTerminatedNCT01479348Early Phase 1Results posted
• Phase II Safety and Efficacy Study of 18FDOPA PET-CT in Children With Hyperinsulinemic HypoglycemiaCompletedNCT01468454Phase 2Results posted
• Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07CompletedNCT01447719Phase 3Results posted
• Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon CleansingCompletedNCT01427296Phase 4Results posted
• Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive DeclineCompletedNCT01400425Phase 3Results posted
• A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.CompletedNCT01347710Phase 3Results posted
• High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed NeuroblastomaCompletedNCT01313936Phase 1Results posted
• Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDSCompletedNCT01300572Phase 1Results posted
• Imaging With a Radio Tracer to Guide VT AblationsCompletedNCT01250912Not applicableResults posted
• F-18 Sodium Fluoride in Prostate CancerCompletedNCT01240551Phase 2Results posted
• Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade HistologiesCompletedNCT01224821Phase 2Results posted
• Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172CompletedNCT01222351Not applicableResults posted
• Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PETCompletedNCT01202994Phase 2Results posted
• GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate CancerTerminatedNCT01176513Phase 2Results posted
• Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem LevelsCompletedNCT01165554Phase 3Results posted
• Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) PatientsCompletedNCT01138111Phase 1Results posted
• Breast and Melanoma Trial With Lymphoseek to Identify Lymph NodesCompletedNCT01106040Phase 3Results posted
• Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure HydrocephalusTerminatedNCT01092546Phase 3Results posted
• Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in TumorsCompletedNCT01075399Phase 2Results posted
• PET Imaging of Brain Amyloid in Normal Pressure HydrocephalusCompletedNCT01053312Phase 3Results posted
• Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's DiseaseCompletedNCT01028053Phase 3Results posted
• Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to HistopathologyCompletedNCT01020838Phase 3Results posted
• Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's LymphomaCompletedNCT00996996Phase 2Results posted
• Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's LymphomaCompletedNCT00989664Phase 2Results posted
• A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLCCompletedNCT00963807Phase 2Results posted
• Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive HistologyCompletedNCT00950755Phase 2Results posted
• Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 AntibodyCompletedNCT00938041Phase 2Results posted
• Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 TositumomabCompletedNCT00933335Phase 2Results posted
• Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.CompletedNCT00928304Phase 2Results posted
• Positron Emission Tomography and Magnetic Resonance Imaging for Prostate CancerCompletedNCT00924313Phase 1/2Results posted
• FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate CancerTerminatedNCT00917865Phase 2Results posted
• Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell CarcinomaTerminatedNCT00911326Phase 3Results posted
• MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00902577Phase 2Results posted
• Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease PatientsCompletedNCT00857532Phase 2Results posted
• Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)CompletedNCT00857506Phase 2Results posted
• Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the BrainCompletedNCT00857415Phase 3Results posted
• Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal IndividualsCompletedNCT00855868Phase 2Results posted
• Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158CompletedNCT00849108Phase 2Results posted
• Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy VolunteersCompletedNCT00750282Phase 2Results posted
• Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00736645Phase 2Results posted
• A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)CompletedNCT00702143Phase 2Results posted
• A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal MetastasesCompletedNCT00699751Phase 3Results posted
• Enema Use and Acceptability in HIV Negative Men Who Have Sex With MenCompletedNCT00696618Not applicableResults posted
• Utility of [F-18] fluoroDOPA for Neonatal HyperinsulinismCompletedNCT00674440Phase 2Results posted
• Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and MelanomaCompletedNCT00671918Phase 3Results posted
• N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk NeuroblastomaCompletedNCT00659984Phase 2Results posted
• Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal AdenocarcinomaTerminatedNCT00625183Phase 2Results posted
• Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-AntibodyCompletedNCT00606632Phase 3Results posted
• Imaging Brain Tumors With FACBC and MethionineCompletedNCT00597246Not applicableResults posted
• Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell TransplantationCompletedNCT00591630Phase 2Results posted
• FDG-PET/CT in the Evaluation of Patients With Suspected CholecystitisCompletedNCT00590395Not applicableResults posted
• Ibritumomab Tiuxetan (Zevalin)+ Rituximab MaintenanceTerminatedNCT00582166Phase 2Results posted
• Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast CancerCompletedNCT00572728Phase 2Results posted
• FACBC PET/CT for Recurrent Prostate CancerCompletedNCT00562315Phase 2Results posted
• Optimizing Treatment for Treatment-Experienced, HIV-Infected PeopleCompletedNCT00537394Phase 3Results posted
• Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRICompletedNCT00537056Not applicableResults posted
• Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive PatientsCompletedNCT00530920Phase 2Results posted
• Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryTerminatedNCT00526890Phase 2Results posted
• Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PITerminatedNCT00517192Phase 3Results posted
• Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary SyndromeCompletedNCT00514501Phase 2Results posted
• Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent LymphomasCompletedNCT00493467Phase 2Results posted
• Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent LymphomasTerminatedNCT00493454Phase 2Results posted
• Zevalin-beam for Aggressive LymphomaCompletedNCT00491491Phase 3Results posted
• Study of Bexxar <Tositumomab> Combined With External Beam Radiation TherapyTerminatedNCT00490490Phase 2Results posted
• Phase 2 Study of Bexxar in Relapsed/Refractory DLCLCompletedNCT00490009Phase 2Results posted
• Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/RitonavirCompletedNCT00486330Not applicableResults posted
• A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's LymphomaTerminatedNCT00479167Phase 2Results posted
• Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First RemissionCompletedNCT00476047Phase 2Results posted
• Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and BexxarTerminatedNCT00475332Phase 2Results posted
• Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/ParagangliomaCompletedNCT00458952Phase 1/2Results posted
• Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone LymphomaCompletedNCT00453102Phase 2Results posted
• SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoCTerminatedNCT00440271Phase 3Results posted
• Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only MetastasesCompletedNCT00429507Phase 2Results posted
• Radioimmunotherapy With 90Y Zevalin for Orbital LymphomaCompletedNCT00387023Not applicableResults posted
• Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal MetastasesCompletedNCT00375830Phase 2Results posted
• Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular LymphomaTerminatedNCT00372905Phase 1/2Results posted
• Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.TerminatedNCT00322218Phase 3Results posted
• Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular LymphomaCompletedNCT00290511Phase 2Results posted
• Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins LymphomaCompletedNCT00268983Phase 3Results posted
• Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.CompletedNCT00199888Phase 1Results posted
• A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki DiseaseCompletedNCT00162032Phase 3Results posted
• Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected SubjectsCompletedNCT00146328Phase 2/3Results posted
• Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)CompletedNCT00144170Phase 3Results posted
• Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal CancerCompletedNCT00142415Phase 1/2Results posted
• Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple MyelomaCompletedNCT00135200Phase 2Results posted
• Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular DiseaseCompletedNCT00126438Phase 3Results posted
• Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular DiseaseCompletedNCT00126425Phase 3Results posted
• S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's LymphomaCompletedNCT00070018Phase 2Results posted
• Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)CompletedNCT00054717Phase 3Results posted
• S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the ProstateCompletedNCT00030901Phase 3Results posted

← Radiopharmaceuticals overview